Additional Patient Response in Pancreatic Cancer Trial
Posted: 6 August 2024 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that a fourth patient enrolled in the Company’s Phase 2a clinical trial investigating narmafotinib in the treatment of advanced pancreatic cancer…
Life-Saving Medical Discovery Centre Hits Major Milestone
Posted: 6 August 2024 The Allan Labor Government is cementing Victoria’s reputation as a global leader in medical research, with Melbourne’s new world-class medical research centre now one step closer to making life-saving scientific discoveries for generations to…
Helping Victoria’s Emerging Researchers Make Their Mark
Posted: 6 August 2024 The Allan Labor Government is backing Victoria’s talented medical researchers to pursue projects that save lives. Minister for Medical Research Ben Carroll today announced that applications are now open for the Labor Government’s Fostering Achievement…
ANDHealth extends CHICC partnership to support rapid growth in commercialisation of Victorian digital & connected health solutions
Posted: 6 August 2024 ANDHealth has today announced the extension of the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) initiative for a further 12 months, off the back of the substantial growth in the local industry over…
Future Health Today And Torch Recruit – Changing The Course Of Chronic Disease
Posted: 6 August 2024 In Australia, accessing primary healthcare through general practitioners (GPs) is a cornerstone of the healthcare system. With more than four in five Australians visiting their GP annually and two million attending weekly, general practice…
AusBiotech appoints Rosanne Hyland Deputy CEO
Posted: 6 August 2024 Ms Rosanne Hyland has been appointed as Deputy Chief Executive Officer of AusBiotech, Australia’s peak association for the life sciences industry, after serving as Business Manager and Chief Operating Officer for five years. Over…
Major Development Milestone Delivered in Optiscan’s Telepathology Platform
Posted: 1 August 2024 Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce the successful completion of the beta phase of its innovative cloud-connected telepathology platform, developed in partnership with Prolucid Technologies. This development represents…
PAT-DX1 GMP manufacturing run update
Posted: 1 August 2024 Patrys Limited. a therapeutic antibody development company, provides the following update regarding the recently completed GMP manufacturing run of PAT-DX1. Patrys’ Contract Development Manufacturing Organization (CDMO) advised the Company that it has identified an…
Help shape the Department of Health’s national audit of the Health and Medical Research Workforce
Posted: 1 August 2024 The Department of Health and Aged Care is conducting a national audit of the Health and Medical Research Workforce, with the findings helping to inform the development of the National Health and Medical Research…
New headquarters for BioMelbourne Network
Posted: 1 August 2024 On 1 August, BioMelbourne Network moved to our new headquarters in Southbank. Please update your records with our new address and phone number. Level 6, HWT Tower, 40 City Road Southbank VIC 3006 New…
Babies offered peanut allergy treatment program under world-first national model
Posted: 31 July 2024 Babies with peanut allergies in Australia will be offered a treatment program under a world-first model aiming to transform allergy care. Ten paediatric hospitals across five states have partnered with the National Allergy Centre of…
MRFF funds new national centre for mRNA medicines
Posted: 31 July 2024 The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $4 million into establishing Australia’s first National Centre for Biopharmaceutical Optimisation of mRNA Therapeutics (CORTx), being led by Monash University to optimise mRNA therapeutic…
